Treatment of GLC1A glaucoma with glucocorticoid antagonists

Details Treatment of GLC1A glaucoma with glucocorticoid antagonists Treatment of GLC1A glaucoma with glucocorticoid antagonists

1997-12-19

2000-07-18

Fay, Zohreh

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514913, A61K 3156

Patent

active

060907983

ABSTRACT:
Compositions of glucocorticoid antagonists for treating mammals suffering from GLC1A glaucoma and methods for their use are disclosed.

REFERENCES:
patent: 4296206 (1981-10-01), Simons, Jr.
patent: 4753932 (1988-06-01), Teutsch et al.
patent: 4774236 (1988-09-01), Cook et al.
patent: 4814327 (1989-03-01), Ottow et al.
patent: 4829060 (1989-05-01), Ottow et al.
patent: 4861763 (1989-08-01), Cook et al.
patent: 4870069 (1989-09-01), Ottow et al.
patent: 4954490 (1990-09-01), Cook et al.
patent: 5073548 (1991-12-01), Cook et al.
patent: 5089488 (1992-02-01), Ottow et al.
patent: 5089635 (1992-02-01), Neef et al.
patent: 5093509 (1992-03-01), Meyer et al.
patent: 5095129 (1992-03-01), Ottow et al.
patent: 5132299 (1992-07-01), Ottow et al.
patent: 5166146 (1992-11-01), Moguilewsky et al.
patent: 5232915 (1993-08-01), Ottow et al.
patent: 5276023 (1994-01-01), Moguilewsky et al.
patent: 5426102 (1995-06-01), Schwede et al.
patent: 5446178 (1995-08-01), Ottow et al.
patent: 5478956 (1995-12-01), Ottow et al.
patent: 5519027 (1996-05-01), Schwede et al.
patent: 5606043 (1997-02-01), Nguyen et al.
"Cellular Mechanisms Influencing the Aqueous Humor Outflow Pathway", Polansky et al, Principles and Practice of Ophtalmology, Jan. 1, 1994, pp. 226-251.
"Steroids, Ocular Hypertension, and Glaucoma", Abbot F. Clark, Ph.D., Journal of Glaucoma, vol. 4, Oct. 1995, pp. 354-369.
Sommer A, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. Arch. Ophthalmol. 109:1090-1095, (1991).
Sheffield, et al., "Genetic Linkage of Familial Open Glaucoma to Chromosome 1q21-q31," Nature Genetics, 4:47-50 (1993).
Sarfarazi, et al., "Assignment of a Locus (GLC3A) for Primary Congenital Glaucoma (Buphthalmos) to 2p21 and Evidence for Genetic Heterogeneity," Genomics, 30:171-177 (1995).
Akarsu, et al., "A Second Locus (GLC3B) for Primary Congenital Glaucoma (Buphthalmos) Maps to the 1p36 Region," Human Molecular Genetics, 5(8):1199-1203 (1996).
Stoilova, et al., "Localization of a Locus (GLC1B) for Adult-Onset Primary Open Angle Glaucoma to the 2cen-q13 Region," Genomics, 36:142-150 (1996).
Wirtz, et al., "Mapping a Gene for Adult-Onset Primary Open-Angle Glaucoma to Chromosome 3q," Am. J. Hum. Genet., 60:296-304 (1997).
Andersen, et al., "A Gene Responsible for the Pigment Dispersion Syndrome Maps to Chromosome 7q35-q36," Arch. Ophthalmol., 115:384-388 (1997).
Richards, et al., "Mapping of a Gene for Autosomal Dominant Juvenile-Onset Open-Angle Glaucoma to Chromosome 1q," Am. J. Hum. Genet., 54:62-70 (1994).
Morissette, et al., "A Common Gene for Juvenile and Adult-Onset Primary Open-Angle Glaucomas Confined on Chromosome 1q," Am. J. Hum. Genet., 56:1431-1442 (1995).
Wiggs, et al., "Genetic Linkage of Autosomal Dominant Juvenile Glaucoma to 1q21-q31 in Three Affected Pedigrees," Genomics, 21:299-303 (1994).
Meyer, et al., "Age-Dependent Penetrance and Mapping of the Locus for Juvenile and Early-Onset Open-Angle Glaucoma on Chromosome 1q (GLC1A) in a French Family," Hum. Genet., 98:567-571 (1996).
Graff, et al., "Confirmation of Linkage to 1q21-31 in a Danish Autosomal Dominant Juvenile-Onset Glaucoma Family and Evidence of Genetic Heterogeneity," Hum. Genet., 96:285-289 (1995).
Stone, et al., "Identification of a Gene That Causes Primary Open Angle Glaucoma," Science, 275:668-670 (1997).
Polansky, et al., "Eicosanoid Production and Glucocorticoid Regulatory Mechanisms in Cultured Human Trabecular Meshwork Cells," The Ocular Effects of Prostaglandins and Other Eicosanoids, pp. 113-138 (1989).
Polansky, et al., "In Vitro Correlates of Glucocorticoid Effects on Intraocular Pressure," Glaucoma Update IV (1991).
Polansky, et al., "Cellular Pharmacology and Molecular Biology of the Trabecular Meshwork Inducible Glucocorticoid Response Gene Product," Ophthalmologica, 211:126-139 (1997).
Ortego, et al., "Cloning and Characterization of Subtracted cDNAs from a Human Ciliary Body Library Encoding TIGR, a Protein Involved in Juvenile Open Angle Glaucoma with Homology to Myosin and Olfactomedin," FEBS Letters, 413:349-353 (1997).
(Kubota, et al., "A Novel Myosin-like Protein (Myocilin) Expressed in the Connecting Cilium of the Photoreceptor: Molecular Cloning, Tissue Expression, and Chromosomal Mapping," Genomics, 41:360-369 (1997).
Sunden, et al., "Fine Mapping of the Autosomal Dominant Juvenile Open Angle Glaucoma (GLC1A) Region and Evaluation of Candidate Genes," Genome Research, 6:862-869 (1996).
Adam, et al., "Recurrent Mutations in a Single Exon Encoding the Evolutionarily Conserved Olfactomedin-Homology Domain of TIGR in Familial Open-Angle Glaucoma," Human Molecular Genetics, 6(12):2091-2097 (1997).
Kass, et al., "Corticosteroid-Induced Glaucoma, In Ritch, R., Shields, M. B., Krupin, T. (eds.)," The Glaucomas, The C. V. Mosby Company, St. Louis, MO, pp. 1161-1168 (1989).
DeSantis, et al., Dexamethasone-Induction of Ocular Hypertension in the Primate, ARVO Abstracts. Invest. Ophthalmol. Vis. Sci., 31(Suppl.):99 (1990).
Knepper, et al., "Intraocular Pressure and Glycosaminoglycan Distribution in the Rabbit Eye: Effect of Age and Dexamethasone," Exp. Eye Res., 27:567-575 (1978).
Francois, et al., Ultrastructural and Morphometric Study of Corticosteroid Glaucoma in Rabbits, Ophthalmic Res., 16:168-178 (1984).
Lorenzetti, O. J., "Effects of Corticosteroids on Ocular Dynamics in Rabbits," J. Pharmacol. Exp. Therap., 175:763-772 (1970).
Zhan, et al., "Steroid Glaucoma: Corticosteroid-Induced Ocular Hypertension in Cats," Exp. Eye Res., 54:211-218 (1992).
Rozsival, et al., "Aqueous Humour and Plasma Cortisol Levels in Glaucoma and Cataract Patients," Current Eye Research, 1:391-396 (1981).
Ray, et al., "Plasma Cortisol in Glaucoma," Ann. Ophthalmol., 9:1151-1154 (1977).
Schwartz, et al., "Increased Plasma Free Cortisol in Ocular Hypertension and Open Angle Glaucoma," Arch. Ophthalmol., 105:1060-1065 (1987).
Wilson, et al., Dexamethasone Induced Ultrastructural Changes in Cultured Human Trabecular Meshwork Cells, Cur. Eye Res., 12:783-793 (1993).
Clark, et al., "Glucocorticoid-Induced Formation of Cross-Linked Actin Networks in Cultured Human Trabecular Meshwork Cells," Invest. Ophthalmol. Vis. Sci., 35:281-294 (1994).
(Green, et al., "Ocular Fluid Dynamics Response to Topical RU486, a Steroid Blocker," Current Eye Research, 4:605-612 (1985).
Tsukahara, et al., "Subconjunctival Suspension of RU486 Lowers Intraocular Pressure in Normal Rabbits," Br. J. Ophthalmol., 70:451-455 (1986).
Denis, et al., "Mifepristone (RU486): In Vitro Binding to Glucocorticoid Receptors in Iris-Cillary Body and In Vivo Effects on Intraocular Pressure in Rabbits," Invest. Ophthalmol. Vis. Sci., 34[Suppl.]:1115 (1993).

Affiliated with

Also associated with

Rating

Treatment of GLC1A glaucoma with glucocorticoid antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of GLC1A glaucoma with glucocorticoid antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of GLC1A glaucoma with glucocorticoid antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2037277